Skip to content
Vensana Capital

Vensana Capital

Transforming Healthcare Through Medtech Innovation

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Uncategorized

Uncategorized

Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

32

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
SpyGlass Pharma Announces Pricing of Initial Public Offering
Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment
Resources
News Vensana Innovation LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2026 Vensana Capital Management, LLC | Privacy | Terms & Conditions